Categories

Category: Matthew Holt

Matthew Holt is the founder and publisher of The Health Care Blog and still writes regularly for the site and hosts the #THCBGang and #HealthInTwoPoint00 video shows/podcasts. He was co-founder of the Health 2.0 Conference and now also does advisory work mostly for health tech startups at his consulting firm SMACK.health.

Health in 2 Point 00, Episode 153 | GoodRx’s massive IPO, Olive, Bright Health & more

Today on Health in 2 Point 00, Jess is in Jacksonville hanging out with Jackson the dog and trying to replace me with @barkyboy. On Episode 153, we cover the biggest IPO we’ve seen yet—GoodRx—with a valuation of $18 billion, which is more than Teladoc, Livongo, and even Cardinal Health. In other news, Olive gets $106 million bringing their total to $220 million; Olive is a back office automation system using AI for hospitals and this round is practically financed by royalty. Bright Health gets $500 million for their health plan; they’ve raised about $1.5 billion and are planning to expand into more markets. Finally Osso VR raised $14 million in a series A, helping surgeons practice performing surgeries through their VR platform. —Matthew Holt

Health in 2 Point 00, Episode 151| MDLive (not?) IPOing, DTx Platform for Schizophrenia, & more

We are forgetting about health tech, and celebrating Chicago-oo! Just kidding, today on Health in 2 Point 00, Jess asks me about Truepill getting a 75M Series C after just closing their B, Sana Benefits getting $20.8M, and Decent getting $10M, both of which are in the space of health benefits & insurance for small business have raised funding, MDLive closing a $50M round for their Virtual Primary Care (but weren’t they going public?), Owl Insights getting $15M from Ascension and Blue Ventures, and Boehringer Ingelheim & Click Therapeutics working on a $500M deal together on a DTx platform for Schizophrenia patients. –Matthew Holt

Continue reading…

Health in 2 Point 00, Episode 150 | Sesquicentennial anniversary edition!

It’s Health in 2 Point 00’s 150th Episode or Sesquicentennial anniversary! On this episode, we have the return of Softbank money—$100M goes to Biofourmis platform for AI & Clinical Trials. Next, Amwell prices their IPO at $14-16 a share, and Grand Rounds raises $175 million led by the Carlyle Group. Finally, we have real foul play to report – former Zocdoc CEO Cyrus Massoumi filed a lawsuit accusing his fellow cofounders and CFO of foul play, so Jess asks me to dish the dirty details. —Matthew Holt

Health in 2 Point 00, Episode 149: Pong & other video games

On today’s Health in 2 Point 00, Jessica is distracted playing video games, and rants about the unbearable maleness of wearables. Meanwhile Komodo Health raises $50m for more analytics (presumably of patients playing Pong), Picnic Health gets $25m as PHRs will not go away, Hazel Health gets $33 million to take telehealth back to school, and then there’s Amazon Halo — and our stars’ alter egos make an appearance — Matthew Holt

Health in 2 Point 00, Episode 148 | A colonoscopy story (& other health tech news)

Today on Health in 2 Point 00, Jess might be a little wary of my colonoscopy story, but it reveals just how well insurance companies communicate. In this episode, Jess and I cover GoodRx filing an S1 to go public, Trellus Health raising $5 million in seed funding for its platform for inflammatory bowel disease (IBD) and other chronic conditions, Klara Health raising $15 million for patient engagement, and Castor raising $12 million for its clinical trial platform. —Matthew Holt

Health in 2 Point 00, Episode 145 | Amwell, OneDrop, Outset Medical & Podimetrics

Today on Health in 2 Point 00, Jess asks me about the big news that Google Cloud has entered into a partnership with Amwell and invested $100 million into the company—looks like their IPO is really a thing! OneDrop gets $98.7 million in a partnership with Bayer, following at $40 million partnership last November, in a funding and development agreement. Outset Medical files their S1 and is going to go public, looking for $100 million for their portable dialysis system, and finally Podimetrics raises another $8 million for their foot ulcer detection platform for diabetics. —Matthew Holt

THCB’s Bookclub, August 2020 – UnHealthcare: A Manifesto for Health Assurance

By JESSICA DAMASSA & MATTHEW HOLT

The THCB Book Club is a discussion with leading health care authors, which will be released on the third Wednesday of every month. And this is the first one!

We kicked off with the new book from Hemant Teneja (VC at General Catalyst who has been writing many big checks lately) and Stephen Klasko (CEO at Jefferson Health System and one of the most unusual hospital system bosses in America). Their book is called UnHealthcare: A Manifesto for Health Assurance which is a how-to for creating a platform for a revolutionary future for health care. You can go buy the book here (eVersion only $6!) It’s an easy read (about 130 pages on your iPad “Books” app).

UnHealthcare is about a new concept called Health assurance– which Tenaja says is “an emerging category of consumer-centric, data-driven healthcare services that are designed to bend the cost curve of care and help us stay well.”

Sitting in on the interview because we can’t get rid of him was Glen Tullman from Livongo (Just kidding, Glen!). He weighed in on how this connects with his new idea of Consumer Directed Virtual Care and the Teladoc-Livongo merger.

This was a great discussion. We had them explain the concept, and pushed them pretty hard on how realistic it was! And you can see it in the video below (and the podcast version will be in our iTunes & Spotify channels very soon)

In September the THCB BookClub will feature Jane Metcalfe with her 2020 book NEO.LIFE

Health in 2 Point 00, Episode 144 | Magical Forests, PsychCentral’s History, & More Funding Rounds

On Episode 144 of Health in 2 Point 00, Matthew has gingerly emerged from his office and gone into a Magical Forest! Jess asks me about Healthline media acquiring PsychCentral, the first-ever online psychiatry support group and I explain the history of how it has been passed around from Corporates to PE firms, Bridge Connector getting 25.5M for its interoperability platform, Cecelia Health raising $13M for its chronic condition management service, and Reify closing $30M to help pharma companies run clinical trials from home. Also, we had our first book club discussion with authors Hemant Teneja (VC at General Catalyst) & Stephen Klasko (CEO at Jefferson Health System) on their book “UnHealthcare: A Manifesto for Health Assurance”. Glen Tullman also made a special guest appearance during the discussion. The episode will be released soon!Matthew Holt

Subscribe To Health in 2 Point 00’s Channel

Matthew Holt on Twitter

Jessica DaMassa on Twitter

Health in 2 Point 00, Episode 142 | Ginger, Infermedica, Xealth & SOC Telemed

Today on Health in 2 Point 00, Jess and I cover all the deals that got overshadowed by the big news of Teladoc and Livongo’s merger. First up is Ginger, the mental health provider which raised $50 million in a D round bringing their total up to $120 million. Infermedica, an AI enabled symptom checker and triage tool, raised $10.25 million in a series A. Next, Xealth landed a $6 million investment from Cerner and LRVHealth, partnering with Cerner and bringing their digital health prescribing tool to Cerner in addition to its current integration with Epic. Finally SOC Telemed is going public through a “reverse” merger with Healthcare Merger Corp. —Matthew Holt

Health in 2 Point 00, Episode 141 | Teladoc Livongo Merger Special

Today, a special Health in 2 Point 00. Jessica DaMassa asks me about the biggest news in public digital health companies ever: this morning’s merger of Teladoc and Livongo. We discuss the deal, the implications for digital health, what’s next for Continuous Clinics, whether our T-Shirts will become a collectors item, and of course what about our book club on August 19! —Matthew Holt

Registration

Forgotten Password?